chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild nausea (today also), Mild Headache (Tylenol fixed it), Racing Pulse (in the mid 80s, usually 59-64 resting rate), low-grade fever.  Fever and high pulse rate are both down, mild nausea/queeziness continues. headache comes and goes (not usual for me) and will take Tylenol if/when needed.
had the Shingrix shots and had a mild case / suspected vaccination failure; had a mild case, I had one light case after getting the shots; itchy; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pruritus. On an unknown date, the outcome of the vaccination failure, shingles and pruritus were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pruritus to be related to Shingrix and Shingrix.  Additional Information: GSK Receipt Date: 27-FEB-2023 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient had shingles twice, he/she had the Shingrix shots and had a mild case of shingles after the shots.  The patient had one light case of shingles after getting the shots and had nothing since. The patient did not had pain, it was just very itchy. The reporter mentioned, it was best to get the shots if at all possible. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details were available. Note: As per narrative description, 2 doses of Shingrix captured as suspect conservatively.
The pt was found in bed at home without a pulse of respirations at 8:00 am on 12/9/00. She was given a glucogon injection and CPR was started and continued until EMS arrived. The pt was intubated and 2 doses of epinephrine and 1 dose of atropine were given during transport to the ER. The pupils were fixed and dilated. At the ER, the pt received epinephrine and atropine in the ER. The pt expired at 9:30 AM on 12/9/00 with cause of death being cardiopulmonary arrest. The pt had taken the normal dose of insulin on 12/8/00 with an accucheck of 147 at 10:20PM on 12/8/00. She had received the flu vaccine at 3:00PM on 12/8/00 in the physicians office. Death certificate states cause of death to be cardiopulmonary arrest. Autopsy report states: pulmonary vascular congestion and edema.
Client reported to pharmacy with complaints of reaction to flu shot. Pharmacist states client had red skin rash upper chest and swollen lips and appeared anxious. Benadryl issued per pharmacy and instructed client to have husband drive her to the emergency room.
This spontaneous report was received from a nurse regarding a patient of unknown age and gender. Information on the concurrent conditions, pertinent medical history and drug allergies were not reported. On 25-JUN-2016, the patient was vaccinated with a properly stored, expired dose of GARDASIL lot #J015378, expiry date 09-APR-2016 (dose number, dose units, route and anatomical location were not reported) (expired product administered). Concomitant mediation were not reported. No adverse reactions were reported. There were no Product Quality Complaint (PQC) involved. Additional information has been requested.
I received the vaccine on Friday April 23. I was pretty certain that the pharmacist gave me the shot too high on my shoulder, because it was unusually high. Went home, shoulder was sore. But Sunday morning, I got up and my arm was in excruciating pain. I could barely lift my hand above my shoulder. That was last Sunday. 8 days have gone by, and the pain level is pretty much the same. I went to the emergency room for the pain last Monday. Then to my normal physician. I now have an appointment with an orthopedic doctor two weeks from now. But in the meantime, I am in a constant state of pain. Shoulder, neck, and high side of my back. Every morning, the pain is what wakes me up. I'm taking way too many pain killers, and I'm afraid it's damaging my stomach, but I hurt constantly so not sure what else to do. I never had any issues like this- until I received my second Pfizer vaccination from Pharmacy. I am pretty certain that the need hit a nerve in my rotator cup.
Sore arm, fever, nauseousness, diarrhea, dizziness, flu like aches and pains, chills, extremely weak.
I injected IPV sub q on (L) vast lateralis when I pulled needle out I noticed pt started developing a welt on her inj site, was hard and swollen.
Pain through out my entire body. Headaches,  hand pain, soar throat,  can't sleep due to severe pain.
Patient requested COVID booster of Moderna Bivalent during routine visit. LPN went to medication area and obtained Pfizer vial instead of Moderna from storage counter. The same LPN had made an error previously. At that time, she obtained Pfizer vial instead of Moderna (even though they are stored in different refrigerator).   Instead of verifying on the vial, she drew up 0.5mL of Pfizer Bivalent and entered the Moderna Bivalent lot number from the daily safety huddle form. Therefore, patient did not receive requested Moderna and received 0.2ml more than suggested Pfizer dose.
Vaccine administered to pt on 4-1-09 after she denied any allergies about 6pm.  Client states on 4-2-09 a red slightly raised rash developed on neck, upper back.  Pt stated she took Benadryl.  Pt stated no pain or itching from rash.  After 5 days of continued rash on neck + upper back she went to her MD.  Dr told her rash was from Hepatitis B vaccine and she should not receive any more Hep B vaccine.  Rash lasted 2 weeks.
Post Paxlovid Rebound; Post Paxlovid Rebound; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Apr2021 at 12:00 as dose 1, single (Lot number: EW0150), in left arm, on 24Apr2021 at 17:00 as dose 2, single (Lot number: EW0164), in left arm and on 17Dec2021 at 17:00 as dose 3 (booster), single (Lot number: FE3594) at the age of 52 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Cerebral Spinal Fluid leak" (unspecified if ongoing), notes: Cerebral Spinal Fluid leak, idiopathic Intracranial Hypertension, depression; "idiopathic Intracranial Hypertension" (unspecified if ongoing), notes: Cerebral Spinal Fluid leak, idiopathic Intracranial Hypertension, depression; "Depression" (unspecified if ongoing), notes: Cerebral Spinal Fluid leak, idiopathic Intracranial Hypertension, depression. The patient's concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Jun2022, outcome "not recovered" and all described as "Post Paxlovid Rebound". Therapeutic measures were taken as a result of covid-19.  Clinical course: The patient received anti viral product for COVID 19 Treatment, brand Paxlovid, treatment start date:01Jun2022, treatment stop date:05Jun2022, lot number:FY8927.
NO C/O PER PATIENT AFTER VACCINE-PT REQUESTED 2ND BOOSTER-AFTER NURSE GAVE BOOSTER IT WAS DISCOVERED IN RECORDS THAT PATIENT HAD 2ND BOOSTER 4/13/22
(Not sure which Meningococcal B vaccine they gave him. The form doesn't specify) Progressed to excrutiating arm pain within 4 hours of shot causing limited mobility, faintness, paleness and shortness of breath when moved arm more than a few inches, inability to work----worst pain he's ever experienced far beyond his prior broken bones or toncilectomy. Debilitating pain lasted approximately 20 hours before it lessened to a tolerable level.  No visible redness or swelling.  Heavy fatigue and loss of appetite lasted 30+ hours.
Sinus pressure started the same night as the vaccine. The symptoms gradually worsened throughout the night. He recognized that the fullness was worse when he was laying down. By the next morning, the fullness became more of a dizziness, he felt unstable, nauseated, weakness, and intermittent tightness in his chest. His symptoms have been mostly stable until this morning (12MAR2021) he woke with a disturbing feeling of fullness in his nose and sinuses. Then suddenly had a significant flow of blood from his RIGHT nostril. As of this evening he still has congestion in his sinuses, and intermittent tightness in his chest.
Initial and follow-up information has been received from a pharmacist concerning a 72 year old female consumer who on 09-MAR-2008 was vaccinated with zoster vaccine live (Oka/Merck). Subsequently, the day after receiving zoster vaccine live (Oka/Merck), on 10-MAR-2008 the patient experienced discomfort on the right side of her cheek and blisters on the inside of the right cheek. The patient reported "rinsing mouth with peroxide on a daily basis." Unspecified medical attention was sought. The patient was diagnosed with ectopic sebaceous glands. There was no relationship to the vaccine or shingles. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
3-23-21 4:07PM BROUGHT TO MEDIC TENT PER WHEELCHAIR - 'FEEELS LIGHTHEADED'. DAD WITH PT. PALE, ORIENTED X3, NO LOC,  RESP WITH EASE, W/D. PLACED ON COT WITH FEET ELEVATED. 4:10PM  PT STATES HE 'FEELS BETTER NOW'. COLOR IMPROVED. 4:12PM HOME WITH DAD - TO EXIT PER WHEEL CHAIR. NO ACUTE OR OBVIOUS DISTRESS. A/O, PINK, W/D, RESP WITH EASE.
on-call provider received a call from patient that she received a flu vaccine in the office 10/24/23.  She reports that starting about 3 days after the vaccine she developed severe pain in the left shoulder.  She thought it was worse than what she had experienced with previous vaccines- but kept thinking she would give it another day and it would go away.  The pain continues.  She reports continued pain that does not respond to 800mg Ibuprofen, OTC tylenol, biofreeze. She denies any localized swelling, skin color changes/bruising/erythema, denies any heat or warmth to the joint, denies fevers.    She reports limited ROM, pain with any movement.
p/vax pt didn't feel good which persisted until 1/4/99;pt exp herpes zoster;MD noted something that looked like herpes zoster 3.5 by 6cm transverse cluster of reddish purple spots on lt buttock;30-50 lesions in one cluster;
Swelling of several lymph nodes in underarm on left with pain.  Had shot Tuesday at 12:55pm - woke up from the under arm pain at 3:30am.  Put myself on a regiment of Advil and Tylenol with the use of ice on swelling for 3 days.  Pain has subsided, but swelling still exist.    Underarm is swollen to the point where I cannot carry my arm down naturally along my body.
Metallic taste in throat; Runny tingly nose nostril; Runny tingly nose nostril; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25Apr2021 at 12:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on unknown date in 2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021 at 12:30, the patient experienced metallic taste in throat, runny tingly nose nostril. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event metallic taste in throat, runny nose and tingly nose nostril was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date in September 2013, the patient was vaccinated with first dose of GARDASIL. On 16-DEC-2013 the patient was vaccinated with third dose GARDASIL. On 16-DEC-2013 the patient was given the third dose of GARDASIL too early. The patient did not experience any adverse effect. The outcome of the event was unknown. Additional information has been requested.
BODY ACHES; MILD FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, and mild fever. The action taken with covid-19 vaccine  was not applicable. The outcome of the mild fever and body aches was not reported. This report was non-serious.
started on 04/09/2021- severe body aches, sweats, chills, severe headaches, pain on left side of face that ran down jaw and into middle of neck, swelling of injection site, sever fatigue. some symptoms are still ongoing.
flu like symptoms for a few days; This is a spontaneous report from a contactable other health care professional and a consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose via an unknown route on an unknown date for Covid-19 immunization. Medial history included rheumatoid arthritis. Concomitant drug included tofacitinib citrate (XELJANZ XR 11 mg) at 11 mg daily orally from May2019 for rheumatoid arthritis. Patient reported 1 night hospitalization for left knee replacement surgery, completed Jun2021, with tofacitinib citrate (XELJANZ) held for 8 weeks per MD order. Patient recalled "some" worsening of rheumatoid arthritis symptoms, improved as of 04Oct2021, no complications reported. Patient reported flu like symptoms for a few days after covid vaccine. Outcome of the event was unknown.
Was sick for 1-1/2 days.  Injection site sore for days. Had chills, just a general feeling of sick to my stomach.
Injection site pain; malaise; fever (38.5ºC); chills; multiple arthralgia; This is a spontaneous report from a contactable Physician (patient). A 44-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EL3247) via intramuscularly in arm left on 22Mar2021 14:00 (age at vaccination 44 years) as dose 2, single for COVID-19 immunization. Medical history included seasonal allergies to pollen, dust and GERD (gastrooesophageal reflux disease) from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (CETRIZINE). No other vaccine in four weeks, no COVID prior vaccination and no COVID tested post vaccination. The patient historical vaccine included received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via intramuscularly in arm left on 01Mar2021 14:00 (age at vaccination 44 years) as dose 1, single for COVID-19 immunization. On 23Mar2021 13:00, the patient experienced injection site pain, malaise, fever (38.5 degree centigrade), chills and multiple arthralgia. On 23Mar2021, the patient underwent lab tests and procedures which included fever: 38.5 degree centigrade. Paracetamol, 650 mg every 6 hrs was received due to events. Therapeutic measures were taken as a result of injection site pain, malaise, fever (38.5 degree centigrade), chills and multiple arthralgia. On an unspecified date in 2021, the outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
Non-ST elevation (NSTEMI) myocardial infarction RESPIRATORY DISTRESS
Ring finger on the right hand felt strange. It started to swell; Ring finger on the right hand felt strange. It started to swell and turn purple; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 at 14:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included MTHFR (Methylenetetrahydrofolate reductase), celiac disease, pneumonia and allergy to wheat. Concomitant medication included supplements (unspecified) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took prochlorperazine maleate (COMPAZINE) and sulfamethoxazole/ trimethoprim (BACTRIM) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 02Apr2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 (also reported as Sunday) at 19:00, in the evening when cooking dinner, the patient felt ring finger on the right hand felt strange and it started to swell and turn purple. The patient was concerned about blood clots. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included rest and ice. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events ring finger on the right hand felt strange and it started to swell and turn purple was resolved with sequelae (also reported as recovered with lasting effects) on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
COGNITIVE DYSFUNCTION; LOW-GRADE FEVER/FOREHEAD WAS HOT; SORE ARM AT THE INJECTION SITE; MUSCLE PAIN QUADS, BACK; This spontaneous report received from a patient concerned a 54 year old male. The patient's weight was 200 pounds, and height was 71 inches. The patient's concurrent conditions included: alcohol use, and non smoker, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. The patient had no any past medications. The patient experienced rash when treated with acetylsalicylic acid, and benzylpenicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 08-SEP-2021 09:00 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, the patient experienced muscle pain quads, back. On 08-SEP-2021, the patient experienced low-grade fever/forehead was hot. On 08-SEP-2021, the patient experienced sore arm at the injection site. On 09-SEP-2021, the patient experienced cognitive dysfunction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low-grade fever/forehead was hot, and sore arm at the injection site on 09-SEP-2021, and had not recovered from muscle pain quads, back, and cognitive dysfunction. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
COVID symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (COVID symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (COVID symptoms). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (COVID symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were reported No treatment medications were reported  Symptoms: Patient experienced COVID symptoms after first dose of Moderna COVID-19 vaccine and was asking if it was safe to get 2nd dose and any timeline to wait for a dose.   Reporter did not allow further contact
8 days after I got the vaccine, the injection site started hurting a little (the original soreness had subsided days ago). There is a large red rash several inches BELOW the injection site that is itchy, and the skin feels lumpy. I know it's not serious, but I am reporting it anyway so that people know what to expect and misinformation doesn't run wild. I still have the rash, 19 hours later...
Pt had extended period of swollen glands and tonsils and sore throat. Vitamin C, vitamins and natural antibiotics used (Echinecea and Golden seal). Gargled with salt water.
Patient received IMZ on 12/30/20.  One 1/7/21 at approximately 2:00pm she developed 2 raised areas on her arm with a valley between. There was also pain in the arm at that area.
Fever, RespDepression, CoughWheeze, Diarrhea, Chills Narrative:
Redness & hard protruding bump at injection site.  Redness is going away per patient.
This is a spontaneous report from a contactable consumer. A patient of unspecified age ethnicity and gender received PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had developed a dry cough after had a pneumococcal 13-val conj vac (dipht crm197 protein) vaccination. The outcome of the event was unknown.